Kristen Pierce
CIK: 0002039649
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CERO THERAPEUTICS HOLDINGS, INC.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 7, 2026CERO
CERO THERAPEUTICS HOLDINGS, INC.
Award(A)DirectStock Option (Right to Buy)
1.6M shares- - May 30, 2025CERO
CERO THERAPEUTICS HOLDINGS, INC.
Award(A)DirectStock Option (Right to Buy)
154.8K shares- - Oct 1, 2024CERO
CERO THERAPEUTICS HOLDINGS, INC.
Award(A)DirectStock Option (Right to Buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 7, 2026 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award(A) Stock Option (Right to Buy) | 1,612,099 | - | - | Direct |
| May 30, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award(A) Stock Option (Right to Buy) | 154,841 | - | - | Direct |
| Oct 1, 2024 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award(A) Stock Option (Right to Buy) | 200,000 | - | - | Direct |
1-3 of 3 transactions
About Pierce Kristen
Pierce Kristen (SEC CIK 0002039649) files insider reports with the SEC as Chief Development Officer of CERO THERAPEUTICS HOLDINGS, INC. (CERO).
Signal8 holds 5 ownership filings by Pierce Kristen (2 Form 3, 3 Form 4), filed between Oct 2, 2024 and Jan 9, 2026. Those filings report 3 transactions, from Oct 1, 2024 to Jan 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Pierce Kristen's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Pierce Kristen
Other insiders filing for CERO THERAPEUTICS HOLDINGS, INC. (CERO)
- Francois Eric, Director
- Rolfe Lindsey, Director
- LAPORTE KATHLEEN, Director
- Patel Shami, Director
- ATWOOD BRIAN G, Director
- Ehrlich Christopher B, Chairman and CEO